and Translation Forum on Drug Discovery, Development – författare

Visar alla böcker från författaren and Translation Forum on Drug Discovery, Development. Handla med fri frakt och snabb leverans.

74 produkter

Innovation in Drug Research and Development for Prevalent Chronic Diseases
Proceedings of a Workshop
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2021
446 kr
Lägg i varukorg
Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as …
Understanding the Benefits and Risks of Pharmaceuticals
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2007
286 kr
Lägg i varukorg
All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a limited understanding of the benefits and risks of drugs, and many individuals believe that drugs approved by the U.S. Food and Drug …
Addressing the Barriers to Pediatric Drug Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2008
295 kr
Lägg i varukorg
Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that …
Challenges for the FDA
The Future of Drug Safety: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2007
437 kr
Lägg i varukorg
As the principal agency regulating food, drugs, medical devices, and biological products used by Americans, the U.S. Food and Drug Administration (FDA) serves one of the most critical consumer protection functions of the federal government. The FDA''s reach is enormous, regulating products that …
Emerging Safety Science
Workshop Summary
Av Sally Robinson, Robert Pool m. fl.
E-bok, 2008
500 kr
Lägg i varukorg
In recent years, the costs of new drug development have skyrocketed. The average cost of developing a new approved drug is now estimated to be $1.3 billion (DiMasi and Grabowski, 2007). At the same time, each year fewer new molecular entities (NMEs) are approved. DiMasi and Grabowski report that …
Breakthrough Business Models
Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Av Institute of Medicine, Board on Health Sciences Policy m. fl.
Häftad, 2009
779 kr
Lägg i varukorg
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and …
Breakthrough Business Models
Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Av Theresa Wizemann, Sally Robinson m. fl.
E-bok, 2009
500 kr
Lägg i varukorg
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and …
Accelerating the Development of Biomarkers for Drug Safety
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2009
295 kr
Lägg i varukorg
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a …
Accelerating the Development of Biomarkers for Drug Safety
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2009
428 kr
Lägg i varukorg
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a …
Public Health Emergency Medical Countermeasures Enterprise
Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary
Av Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development m. fl.
E-bok, 2010
580 kr
Lägg i varukorg
During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public''s well-being. The Public Health Emergency Medical Countermeasures …
Transforming Clinical Research in the United States
Challenges and Opportunities: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2010
500 kr
Lägg i varukorg
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides …
Public Health Emergency Medical Countermeasures Enterprise
Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary
Av Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development m. fl.
E-bok, 2010
831 kr
Lägg i varukorg
During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public''s well-being. The Public Health Emergency Medical Countermeasures …
Building a National Framework for the Establishment of Regulatory Science for Drug Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2011
295 kr
Lägg i varukorg
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA''s science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the …
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa
Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2011
491 kr
Lägg i varukorg
Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …
Direct-to-Consumer Genetic Testing
Summary of a Workshop
Av and Law Committee on Science, Technology, Policy and Global Affairs m. fl.
E-bok, 2010
393 kr
Lägg i varukorg
Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be …
New Profile of Drug-Resistant Tuberculosis in Russia
A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2011
506 kr
Lägg i varukorg
An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is …
Transforming Clinical Research in the United States
Challenges and Opportunities: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2010
714 kr
Lägg i varukorg
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides …
Breakthrough Business Models
Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Av Theresa Wizemann, Sally Robinson m. fl.
E-bok, 2009
698 kr
Lägg i varukorg
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and …
Emerging Safety Science
Workshop Summary
Av Sally Robinson, Robert Pool m. fl.
E-bok, 2008
714 kr
Lägg i varukorg
In recent years, the costs of new drug development have skyrocketed. The average cost of developing a new approved drug is now estimated to be $1.3 billion (DiMasi and Grabowski, 2007). At the same time, each year fewer new molecular entities (NMEs) are approved. DiMasi and Grabowski report that …
Addressing the Barriers to Pediatric Drug Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2008
428 kr
Lägg i varukorg
Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that …
Challenges for the FDA
The Future of Drug Safety: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2007
628 kr
Lägg i varukorg
As the principal agency regulating food, drugs, medical devices, and biological products used by Americans, the U.S. Food and Drug Administration (FDA) serves one of the most critical consumer protection functions of the federal government. The FDA''s reach is enormous, regulating products that …
Understanding the Benefits and Risks of Pharmaceuticals
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2007
428 kr
Lägg i varukorg
All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a limited understanding of the benefits and risks of drugs, and many individuals believe that drugs approved by the U.S. Food and Drug …
Adverse Drug Event Reporting
The Roles of Consumers and Health-Care Professionals: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2007
428 kr
Lägg i varukorg
Recent concerns about the unexpected adverse effects of marketed drugs, such as COX-2 (cyclooxygenase-2) inhibitors or specific statins, raise concerns not only about reporting these events during premarket studies, but also about the responsibility for ongoing surveillance of drugs once they are …
Direct-to-Consumer Genetic Testing
Summary of a Workshop
Av and Law Committee on Science, Technology, Policy and Global Affairs m. fl.
E-bok, 2010
571 kr
Lägg i varukorg
Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be …
Building a National Framework for the Establishment of Regulatory Science for Drug Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2011
428 kr
Lägg i varukorg
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA''s science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the …
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa
Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2011
696 kr
Lägg i varukorg
Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …
Advancing Regulatory Science for Medical Countermeasure Development
Workshop Summary
Av Institute of Medicine, Board on Health Sciences Policy m. fl.
Häftad, 2011
485 kr
Lägg i varukorg
Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community …
Advancing Regulatory Science for Medical Countermeasure Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Forum on Medical and Public Health Preparedness for Catastrophic Events m. fl.
E-bok, 2011
615 kr
Lägg i varukorg
Whether or not the United States has safe and effective medical countermeasures—such as vaccines, drugs, and diagnostic tools—available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at …
Advancing Regulatory Science for Medical Countermeasure Development
Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Forum on Medical and Public Health Preparedness for Catastrophic Events m. fl.
E-bok, 2011
641 kr
Lägg i varukorg
Whether or not the United States has safe and effective medical countermeasures—such as vaccines, drugs, and diagnostic tools—available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at …
Public Engagement and Clinical Trials
New Models and Disruptive Technologies: Workshop Summary
Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.
E-bok, 2012
576 kr
Lägg i varukorg
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition …